Content area

Abstract

Background

Diagnosis of atypical breast lesions (ABLs) leads to unnecessary surgery in 75–90% of women. We have previously developed a model including age, complete radiological target excision after biopsy, and focus size that predicts the probability of cancer at surgery. The present study aimed to validate this model in a prospective multicenter setting. –

Methods

Women with a recently diagnosed ABL on image-guided biopsy were recruited in 18 centers, before wire-guided localized excisional lumpectomy. Primary outcome was the negative predictive value (NPV) of the model.

Results

The NOMAT model could be used in 287 of the 300 patients included (195 with ADH). At surgery, 12 invasive (all grade 1), and 43 in situ carcinomas were identified (all ABL: 55/287, 19%; ADH only: 49/195, 25%). The area under the receiving operating characteristics curve of the model was 0.64 (95% CI 0.58–0.69) for all ABL, and 0.63 for ADH only (95% CI 0.56–0.70). For the pre-specified threshold of 20% predicted probability of cancer, NPV was 82% (77–87%) for all ABL, and 77% (95% CI 71–83%) for patients with ADH. At a 10% threshold, NPV was 89% (84–94%) for all ABL, and 85% (95% CI 78-–92%) for the ADH. At this threshold, 58% of the whole ABL population (and 54% of ADH patients) could have avoided surgery with only 2 missed invasive cancers.

Conclusion

The NOMAT model could be useful to avoid unnecessary surgery among women with ABL, including for patients with ADH.

Clinical Trial registration: NCT02523612.

Details

Title
Prospective Multicenter Study Validate a Prediction Model for Surgery Uptake Among Women with Atypical Breast Lesions
Author
Uzan, Catherine 1 ; Mazouni Chafika 2 ; Rossoni Caroline 2 ; De Korvin Brigitte 3 ; de Lara Christine Tunon 4 ; Cohen, Monique 5 ; Chabbert Nathalie 6 ; Zilberman, Sonia 6 ; Boussion Veronique 7 ; Vincent, Salomon Anne 8 ; Espie, Marc 9 ; Coutant, Charles 10 ; Marchal, Frederic 11 ; Salviat Flore 12 ; Boulanger Loic 13 ; Doutriaux-Dumoulin Isabelle 14 ; Jouve, Eva 15 ; Mathelin Carole 16 ; de Saint hilaire Pierre 17 ; Mollard Joelle 18 ; Balleyguier Corinne 2 ; Joyon Natacha 2 ; Triki Magali Lacroix 2 ; Delaloge Suzette 2 ; Michiels, Stefan 2 

 Pitié-Salpêtrière University Hospital, AP-HP (Assistance Publique des Hôpitaux de Paris), Department of Gynecological and Breast Surgery and Oncology, Paris, France (GRID:grid.411439.a) (ISNI:0000 0001 2150 9058); Sorbonne University, INSERM UMR_S_938, “Cancer Biology and Therapeutics”, Centre de Recherche Saint-Antoine (CRSA), Paris, France (GRID:grid.465261.2) (ISNI:0000 0004 1793 5929); Institut Universitaire de Cancérologie (IUC), Paris, France (GRID:grid.465261.2) 
 Gustave Roussy, Villejuif, France (GRID:grid.14925.3b) (ISNI:0000 0001 2284 9388) 
 Radiology Center, Centre Eugène Marquis, CHU Rennes, Rennes, France (GRID:grid.14925.3b) 
 Institut Bergonié, Bordeaux, France (GRID:grid.476460.7) (ISNI:0000 0004 0639 0505) 
 Institut Paoli Calmettes, Marseille, France (GRID:grid.418443.e) (ISNI:0000 0004 0598 4440) 
 Hôpital Tenon, Sorbonne University, Paris, France (GRID:grid.418443.e) 
 Centre Jean Perrin, Clermont-Ferrand, France (GRID:grid.418113.e) (ISNI:0000 0004 1795 1689) 
 Institut Curie, Université Paris-Sciences Lettres, INSERM U934, Département de Médecine Diagnostique et Théranostique, Paris, France (GRID:grid.418113.e) 
 University of Paris, Hôpital Saint Louis, APHP, Paris, France (GRID:grid.418113.e) 
10  Centre Georges François Leclerc, Dijon, France (GRID:grid.418037.9) (ISNI:0000 0004 0641 1257) 
11  Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France (GRID:grid.452436.2) (ISNI:0000 0000 8775 4825) 
12  Gustave Roussy, Service de Biostatistique et d’Épidémiologie, Villejuif, France (GRID:grid.14925.3b) (ISNI:0000 0001 2284 9388); CESP INSERM U1018, Université Paris-Sud, Université Paris-Saclay, Villejuif, France (GRID:grid.5842.b) (ISNI:0000 0001 2171 2558) 
13  Centre Oscar Lambret, Lille, France (GRID:grid.452351.4) (ISNI:0000 0001 0131 6312) 
14  Institut Cancérologique de l’ouest, Saint-Herblain, France (GRID:grid.452351.4) 
15  Institut Claudius Regaud-Oncopole, Toulouse, France (GRID:grid.417829.1) (ISNI:0000 0000 9680 0846) 
16  Les Hôpitaux universitaires de Strasbourg, Strasbourg, France (GRID:grid.412220.7) (ISNI:0000 0001 2177 138X) 
17  Hôpital de la Croix-Rousse, Lyon, France (GRID:grid.413306.3) (ISNI:0000 0004 4685 6736) 
18  CHU Dupuytren, Limoges, France (GRID:grid.412212.6) (ISNI:0000 0001 1481 5225) 
Pages
2138-2145
Publication year
2021
Publication date
Apr 2021
Publisher
Springer Nature B.V.
ISSN
10689265
e-ISSN
15344681
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2498798778
Copyright
© Society of Surgical Oncology 2020.